E-LIB Suche - Ergebnisse für: Eisen, T.

1

First-line treatment of metastatic clear cell renal cell ca..:

Aeppli, S. ; Schmaus, M. ; Eisen, T....
ESMO Open. 6 (2021) 1 - p. 100030 , 2021

Link: https://doi.org/10.1016/..

2

Locus of control is associated with tobacco and alcohol con..:

Lassi, G. ; Taylor, A. E. ; Mahedy, L....
Royal Society Open Science. 6 (2019) 3 - p. 181133 , 2019

Link: https://doi.org/10.1098/..

3

Second-line treatment for metastatic clear cell renal cell ..:

Rothermundt, C. ; von Rappard, J. ; Eisen, T....
World Journal of Urology. 35 (2016) 4 - p. 641-648 , 2016

Link: https://doi.org/10.1007/..

4

A randomised, phase II study of nintedanib or sunitinib in ..:

Eisen, T ; Loembé, A-B ; Shparyk, Y...
British Journal of Cancer. 113 (2015) 8 - p. 1140-1147 , 2015

Link: https://doi.org/10.1038/..

5

Prospective study evaluating the relative sensitivity of 18..:

Gerety, E.L. ; Lawrence, E.M. ; Wason, J....
Annals of Oncology. 26 (2015) 10 - p. 2113-2118 , 2015

Link: https://doi.org/10.1093/..

6

17LBA Results from an open-label, randomized, controlled Ph..:

Rini, B. ; Stenzl, A. ; Zdrojowy, R....
European Journal of Cancer. 51 (2015) - p. S718 , 2015

Link: https://doi.org/10.1016/..

7

Assessing the impact of evolving evidence in renal cell car..:

Gore, M.E. ; Bellmunt, J. ; Eisen, T....
European Journal of Cancer. 50 (2014) 18 - p. 3153-3160 , 2014

Link: https://doi.org/10.1016/..

8

Common variation at 2q22.3 (ZEB2) influences the risk of re..:

Henrion, M. ; Frampton, M. ; Scelo, G....
Human Molecular Genetics. 22 (2013) 10 - p. 2128-2128 , 2013

Link: https://doi.org/10.1093/..

9

81 The uniqueness of the United Kingdom Lung Cancer Screeni..:

McRonald, F. ; Baldwin, D.R. ; Devaraj, A....
Lung Cancer. 79 (2013) - p. S28-S29 , 2013

Link: https://doi.org/10.1016/..

10

Evaluation of treatment options for patients with advanced ..:

Gore, M.E. ; Bellmunt, J. ; Eisen, T....
European Journal of Cancer. 48 (2012) 7 - p. 1038-1047 , 2012

Link: https://doi.org/10.1016/..

11

Targeted Therapies for Renal Cell Carcinoma: Review of Adve..:

Eisen, T. ; Sternberg, C. N. ; Robert, C....
JNCI Journal of the National Cancer Institute. 104 (2012) 2 - p. 93-113 , 2012

Link: https://doi.org/10.1093/..

12

O4 Tivozanib hydrochloride versus sorafenib as initial targ..:

Motzer, R. ; Nosov, D. ; Eisen, T....
European Urology Supplements. 11 (2012) 5 - p. 185 , 2012

Link: https://doi.org/10.1016/..

13

Fatal case of sorafenib-associated idiosyncratic hepatotoxi..:

Fairfax, BP ; Pratap, S ; Roberts, ISD...
BMC Cancer. 12 (2012) 1 - p. , 2012

Link: https://doi.org/10.1186/..

14

7114 POSTER DISCUSSION Appropriateness of Treatment Options..:

Gore, M. ; Bellmunt, J. ; Eisen, T....
European Journal of Cancer. 47 (2011) - p. S508-S509 , 2011

Link: https://doi.org/10.1016/..

15

718 SORAFENIB (SOR) DOSAGE PATTERNS IN OLDER PATIENTS (PTS)..:

Bracarda, S. ; Bokemeyer, C. ; Procopio, G....
European Urology Supplements. 10 (2011) 2 - p. 229 , 2011

Link: https://doi.org/10.1016/..